Discontinuation report PRO-NAPROXEN EC - 375
| Report ID | 84067 |
| Drug Identification Number | 02310945 |
| Brand name | PRO-NAPROXEN EC - 375 |
| Common or Proper name | PRO-NAPROXEN EC - 375 |
| Company Name | PRO DOC LIMITEE |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | NAPROXEN |
| Strength(s) | 375MG |
| Dosage form(s) | TABLET (ENTERIC-COATED) |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | M01AE |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2019-11-15 |
| Actual discontinuation date | 2019-11-04 |
| Remaining supply date | 2020-02-29 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
| Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2019-11-05 | English | Compare |
| v6 | 2019-11-04 | French | Compare |
| v5 | 2019-11-04 | English | Compare |
| v4 | 2019-06-19 | French | Compare |
| v3 | 2019-06-19 | English | Compare |
| v2 | 2019-05-14 | French | Compare |
| v1 | 2019-05-14 | English | Compare |
Showing 1 to 7 of 7